Is Prenetics Global Limited Class A Ordinary Share a good investment? Prenetics Global Limited Class A Ordinary Share (PRE) is currently trading at 14.54 USD.
Earnings Schedule: Prenetics Global Limited Class A Ordinary Share is expected to release its next earnings report on Sept. 11, 2026. The market consensus estimate for Forward EPS is -0.68.
No, it does not currently pay a dividend.
Prenetics Global Limited Class A Ordinary Share is classified as a Stock.
The next earnings date is projected to be Sept. 11, 2026. The company currently has a trailing EPS of -2.46.
Prenetics Global Limited, a health sciences company, focuses on consumer health in Hong Kong and the United States. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide insights into health, wellness, and genetic predispositions. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Community Discussion